Literature DB >> 20452480

Was the preterm birth rate in the placebo group too high in the Meis MFMU Network trial of 17-OHPC?

Jay D Iams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20452480     DOI： 10.1016/j.ajog.2010.03.020

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  3 in total

Review 1.  Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.

Authors:  Roberto Romero; Frank Z Stanczyk
Journal:  Am J Obstet Gynecol       Date:  2013-04-30       Impact factor: 8.661

2.  17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth - A Systematic Review and Meta-analysis Taking into Account the PROLONG Trial.

Authors:  Ruben-J Kuon; Richard Berger; Werner Rath
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-01-19       Impact factor: 2.915

3.  Re-examining the Meis Trial for Evidence of False-Positive Results.

Authors:  Baha Sibai; George R Saade; Anita F Das
Journal:  Obstet Gynecol       Date:  2020-09       Impact factor: 7.623
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.